Paradigm Biocapital Advisors LP

Paradigm Biocapital Advisors LP reported 30 holdings worth US$5.03B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Paradigm Biocapital Advisors LP reported 30 holdings worth US$5.03B as of Sep 30, 2026. Largest: Revolution Medicines, Inc., Genmab A/S and Edgewise Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
30
Value as reported
US$5.03B

The filing in full

CompanySharesValue as reported% of portfolio
Revolution Medicines, Inc.6.22MUS$1.28B25.4%
Genmab A/S14.1MUS$504M10.0%
Edgewise Therapeutics, Inc.10.8MUS$438M8.7%
Spyre Therapeutics, Inc.4.46MUS$397M7.9%
Insmed Incorporated2.7MUS$308M6.1%
MBX Biosciences, Inc.3.77MUS$221M4.4%
Oruka Therapeutics, Inc.2.49MUS$208M4.1%
Belite Bio, Inc.1.14MUS$194M3.9%
Tarsus Pharmaceuticals, Inc.2.3MUS$181M3.6%
Tango Therapeutics, Inc.6.96MUS$174M3.5%
Viridian Therapeutics, Inc.8.26MUS$170M3.4%
BridgeBio Pharma, Inc.2.35MUS$154M3.1%
Vaxcyte, Inc.2.14MUS$122M2.4%
Erasca, Inc.8MUS$117M2.3%
Jade Biosciences, Inc.6.05MUS$85M1.7%
Tyra Biosciences, Inc.3.51MUS$76.8M1.5%
Olema Pharmaceuticals, Inc.8.72MUS$75.3M1.5%
Obsidian Therapeutics, Inc.4.16MUS$57.1M1.1%
Structure Therapeutics, Inc.1.3MUS$40.6M0.81%
Achieve Life Sciences, Inc.4.95MUS$40.1M0.80%
Veradermics, Incorporated310KUS$37.6M0.75%
Assembly Biosciences, Inc.1.55MUS$36.5M0.73%
ORIC Pharmaceuticals, Inc.1.51MUS$20.3M0.40%
Editas Medicine, Inc.7.58MUS$19.5M0.39%
Hemab Therapeutics Holdings, Inc.629KUS$19.4M0.39%
Vor Biopharma Inc.890KUS$17M0.34%
Kardigan, Inc.900KUS$13.3M0.26%
TCGX Acquisition Corp.300KUS$3.75M0.07%
Inventiva SA808KUS$2.98M0.06%
Nuvalent, Inc.0US$00.00%
Alnylam Pharmaceuticals, Inc.0US$00.00%
Apogee Therapeutics, Inc.0US$00.00%
EyePoint, Inc.0US$00.00%
Lexeo Therapeutics, Inc.0US$00.00%
MapLight Therapeutics, Inc.0US$00.00%

Source

Download original · View original at SEC

Related